Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep;39(12):2284-2291.
doi: 10.1007/s11606-024-08705-x. Epub 2024 Mar 8.

Tackling Guideline Non-concordance: Primary Care Barriers to Incorporating Life Expectancy into Lung Cancer Screening Decision-Making-A Qualitative Study

Affiliations

Tackling Guideline Non-concordance: Primary Care Barriers to Incorporating Life Expectancy into Lung Cancer Screening Decision-Making-A Qualitative Study

Lauren Kearney et al. J Gen Intern Med. 2024 Sep.

Abstract

Background: Primary care providers (PCPs) are often the first point of contact for discussing lung cancer screening (LCS) with patients. While guidelines recommend against screening people with limited life expectancy (LLE) who are less likely to benefit, these patients are regularly referred for LCS.

Objective: We sought to understand barriers PCPs face to incorporating life expectancy into LCS decision-making for patients who otherwise meet eligibility criteria, and how a hypothetical point-of-care tool could support patient selection.

Design: Qualitative study based on semi-structured telephone interviews.

Participants: Thirty-one PCPs who refer patients for LCS, from six Veterans Health Administration facilities.

Approach: We thematically analyzed interviews to understand how PCPs incorporated life expectancy into LCS decision-making and PCPs' receptivity to a point-of-care tool to support patient selection. Final themes were organized according to the Cabana et al. framework Why Don't Physicians Follow Clinical Practice Guidelines, capturing the influence of clinician knowledge, attitudes, and behavior on LCS appropriateness determinations.

Key results: PCP referrals to LCS for patients with LLE were influenced by limited knowledge of the life expectancy threshold at which patients are less likely to benefit from LCS, discomfort estimating life expectancy, fear of missing cancer at the point of early detection, and prioritization of factors such as quality of life, patient values, clinician-patient relationship, and family support. PCPs were receptive to a decision support tool to inform and communicate LCS appropriateness decisions if easy to use and integrated into clinical workflows.

Conclusions: Our study suggests knowledge gaps and attitudes may drive decisions to offer screening despite LLE, a behavior counter to guideline recommendations. Integrating a LCS decision support tool that incorporates life expectancy within the electronic medical record and existing clinical workflows may be one acceptable solution to improve guideline concordance and increase confidence in selecting high benefit patients for LCS.

Keywords: decision support tools; life expectancy; lung cancer screening; patient-centered care.

PubMed Disclaimer

Conflict of interest statement

Dr. Caverly has an open-source license for a free, web-based tool to support shared decision-making for lung cancer screening (Decision Precision, screenLC.com). He receives no payments or royalties. Dr. Wiener serves as Associate Documents Editor (paid) for the American Thoracic Society, as well as in several unpaid leadership roles related to lung cancer screening policy for professional societies including the American Thoracic Society, American College of Chest Physicians, American College of Radiology, and American Cancer Society National Lung Cancer Round Table.

Similar articles

Cited by

References

    1. Aberle DR, DeMello S, Berg CD, et al. Results of the Two Incidence Screenings in the National Lung Screening Trial. N Engl J Med 2013;369(10):920–931. 10.1056/NEJMoa1208962 - DOI - PMC - PubMed
    1. Koning H de, Meza R, Plevritis SK, et al. Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the US Preventive Services Task Force. Ann Intern Med 2014;160(5):311-+. - PMC - PubMed
    1. American Cancer Society lung cancer screening guidelines - Wender - 2013 - CA: A Cancer Journal for Clinicians - Wiley Online Library [Internet]. [cited 2022 Jul 13];Available from: https://acsjournals-onlinelibrary-wiley-com.ezproxy.bu.edu/doi/full/10.3... - DOI - PMC - PubMed
    1. Mazzone PJ, Silvestri GA, Patel S, et al. Screening for Lung Cancer. Chest 2018;153(4):954–985. 10.1016/j.chest.2018.01.016 - DOI - PubMed
    1. US Preventive Services Task Force, Krist AH, Davidson KW, et al. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2021;325(10):962. - PubMed

LinkOut - more resources